E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high13.25 22/06/17
52 week low6.00 01/06/17
52 week change 1.38 (14.86%)
4 week volume941,765 23/09/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Edison issues update on e-Therapeutics (ETX)

Edison Investment Research Limited Edison issues update on e-Therapeutics (ETX) 05-Oct-2017 / 11:34 GMT/BST London, UK, 5 October 2017 Edison issues update on e-Therapeutics (ETX) e-Therapeutics' (ETX) interim numbers demonstrate tight cost control and focus on the rationalised pipeline, with continued investment into the Network-Driven Drug Discovery pla...

Interim Results for 6 Months Ended 31 July 2017

RNS Number: 7667R e-Therapeutics plc 26 September 2017 e-Therapeutics ('e-Therapeutics' or the 'Company') Interim Results for the 6 Months Ended 31 July 2017 Executing Against Plan with Reduced Loss and Lower Cash Burn Oxford, UK, 26 September 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) t...

e-therapeutics schedules interims

e-therapeutics will announce its results for the six months ended 31 July on 26 September. At 9:47am: (LON:ETX) eTherapeu...

Notice of Results

RNS Number: 8457P e-Therapeutics plc 05 September 2017 E-THERAPEUTICS PLC ("e-therapeutics" or the "Company") Notification of Half Year Results Date Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six month...

Director Deals - e-Therapeutics PLC (ETX)

Iain Ross, Chairman, bought 250,000 shares in the company on the 22nd August 2017 at a price of 10.60p. The Director now...

Director Deals - e-Therapeutics PLC (ETX)

Iain Ross, Chairman, bought 250,000 shares in the company on the 22nd August 2017 at a price of 10.60p. The Director now...

Director/PDMR Shareholding

RNS Number: 6882O e-Therapeutics plc 22 August 2017 E-THERAPEUTICS PLC ("e-therapeutics" or the "Company") NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES Oxford, UK, 22 August 2017 - e-therapeutics plc (AIM: ETX), the computer-based drug discovery platform ...

Edison issues update on e-Therapeutics

Edison has issued an update on e-Therapeutics following the business and strategic review undertaken by new chief execut...

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..
LLOYDS GRP.28%
ROCKHOPPER28%
RENEURON24%
RANGE RES.24%
ID:ISIN:VGG9828A119420%

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX